『JACC Editor's Page』のカバーアート

JACC Editor's Page

JACC Editor's Page

著者: American College of Cardiology
無料で聴く

このコンテンツについて

Go beyond the headlines with Harlan M. Krumholz, MD, SM, FACC, Editor-in-Chief of JACC, as he shares reflections on the science, ideas, and issues shaping cardiovascular medicine today.American College of Cardiology Foundation. All rights reserved. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • JACC Editor's Page: August 26, 2025 | JACC
    2025/08/18

    This update to the JACC Report Card highlights ongoing disparities in cardiovascular mortality between Black and White Americans. While some metrics, such as ischemic heart disease, show modest improvement, excess age-adjusted mortality rates and years of potential life lost remain alarmingly high for Black Americans. These findings reinforce the urgent need for structural reform, sustained investment, and accountability to close persistent gaps in cardiovascular outcomes.

    続きを読む 一部表示
    5 分
  • Editor's Page: August 19, 2025 | JACC
    2025/08/11

    Cardiovascular devices are at the heart of modern clinical practice, yet gaps in surveillance, reporting, and clinician awareness continue to pose serious risks to patient safety. This week’s Editor’s Page highlights the urgent need for improved transparency, stronger reporting systems, and clinician-led engagement around device recalls. With expert perspectives on FDA oversight, the role of unique device identifiers (UDI), and opportunities for real-time communication and consensus-building, this commentary challenges the cardiovascular community to take an active role in shaping the future of device safety. By addressing long-standing misconceptions and systemic limitations, it calls for smarter systems, faster responses, and shared accountability in delivering safe and effective cardiovascular care.

    続きを読む 一部表示
    8 分
  • Editor's Page: August 12, 2025 | JACC
    2025/08/08

    Therapeutic breakthroughs in ATTR cardiomyopathy have ushered in a new era of treatment, with gene silencers, stabilizers, and next-generation therapies extending life and improving quality for patients once left with few options. Yet this progress has exposed a profound and growing divide—between innovation and access. This week’s Editor’s Page explores the striking disconnect between clinical value and global affordability, calling attention to pricing challenges, equity gaps, and the real-world implications of cost-based care limitations. By highlighting the urgency of equitable implementation alongside scientific success, the issue urges clinicians, manufacturers, policymakers, and journals to work together in shaping a future where life-changing therapies reach all who need them.

    続きを読む 一部表示
    8 分
まだレビューはありません